These signals are not yet the same as definitive proof of prevention, but they are promising enough to merit discussion with your clinician if youre already a candidate for these drugs for diabetes, obesity, or cardiometabolic risk
DPP-4 inhibitors , such as sitagliptin, enhance the bodys own ability to lower blood sugar
: -
SUSTAIN Trials: These trials focused on subcutaneous semaglutide, highlighting its safety and effectiveness in managing Type 2 diabetes
Studies examining glutathione supplementation have used widely varying doses, typically ranging from 250 mg to 1,000 mg daily for reduced glutathione, though optimal dosing remains undetermined
Anxiety has been noted in some users, potentially related to hormonal shifts, changes in gut-brain signaling through the vagus nerve, or the psychological impact of rapid body changes